Glucotrack receives Nasdaq delisting notice for bid price non-compliance; plans to appeal

Glucotrack, Inc.

Nasdaq notified Glucotrack on April 2, 2025 of delisting due to bid price below $1.00 for 30 consecutive business days.
Company intends to request a hearing by April 9, 2025, which will stay the suspension pending Panel decision.
Compliance with Bid Price Rule was previously regained in November 2024; now again non-compliant.
No immediate impact on trading under symbol GCTK; outcome of appeal uncertain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.